Continuation pharmacotherapy of borderline personality disorder with haloperidol and phenelzine
- 1 December 1993
- journal article
- clinical trial
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 150 (12) , 1843-1848
- https://doi.org/10.1176/ajp.150.12.1843
Abstract
The aim of this study was to assess the effectiveness of low-dose neuroleptic medication and monoamine oxidase inhibitor (MAOI) antidepressant medication in continuation pharmacotherapy of patients with borderline personality disorder.Keywords
This publication has 0 references indexed in Scilit: